Akarsu Emel Oguz, Surmeli Reyhan, Yalcin Destina
Department of Neurology, Ersin Aslan State Hospital, Gaziantep, Turkey.
Department of Neurology, Umraniye Training and Research Hospital, Istanbul, Turkey.
North Clin Istanb. 2015 Jan 24;1(3):187-190. doi: 10.14744/nci.2014.28247. eCollection 2014.
Myoclonus-dystonia syndrome (MDS) is a rare disease manifesting myoclonus as the only neurological symptom which may be accompanied by dystonia. It usually starts in the first or second decade of life. It has a benign course with spontaneous remissions but can cause functional disability in some patients. In this paper, we report a patient diagnosed as probable MDS on the basis of clinical and electrophysiological features who showed marked improvement under levetiracetam treatment.
肌阵挛性肌张力障碍综合征（MDS）是一种罕见疾病，以肌阵挛作为唯一的神经症状，可能伴有肌张力障碍。它通常在生命的第一个或第二个十年开始发病。其病程良性，有自发缓解情况，但在一些患者中可导致功能残疾。在本文中，我们报告了一名根据临床和电生理特征被诊断为可能患有MDS的患者，该患者在左乙拉西坦治疗下有显著改善。
